NO20073664L - Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet - Google Patents
Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitetInfo
- Publication number
- NO20073664L NO20073664L NO20073664A NO20073664A NO20073664L NO 20073664 L NO20073664 L NO 20073664L NO 20073664 A NO20073664 A NO 20073664A NO 20073664 A NO20073664 A NO 20073664A NO 20073664 L NO20073664 L NO 20073664L
- Authority
- NO
- Norway
- Prior art keywords
- neuropeptide
- receptor
- peptides
- agonist activity
- obesity
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57545—Neuropeptide Y
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64484005P | 2005-01-18 | 2005-01-18 | |
PCT/EP2006/000161 WO2006077035A1 (en) | 2005-01-18 | 2006-01-11 | Peptides with neuropeptide-2 receptor (y2r) agonist activity |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20073664L true NO20073664L (no) | 2007-09-28 |
Family
ID=36118121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20073664A NO20073664L (no) | 2005-01-18 | 2007-07-17 | Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet |
Country Status (22)
Country | Link |
---|---|
US (1) | US7410949B2 (zh) |
EP (1) | EP1844070B1 (zh) |
JP (1) | JP4633804B2 (zh) |
KR (1) | KR100905380B1 (zh) |
CN (1) | CN101107266A (zh) |
AR (1) | AR051904A1 (zh) |
AT (1) | ATE500268T1 (zh) |
AU (1) | AU2006207659B2 (zh) |
BR (1) | BRPI0606675A2 (zh) |
CA (1) | CA2594423A1 (zh) |
DE (1) | DE602006020407D1 (zh) |
DK (1) | DK1844070T3 (zh) |
ES (1) | ES2359850T3 (zh) |
IL (1) | IL184428A0 (zh) |
MX (1) | MX2007008614A (zh) |
NO (1) | NO20073664L (zh) |
PL (1) | PL1844070T3 (zh) |
PT (1) | PT1844070E (zh) |
RU (1) | RU2383553C2 (zh) |
TW (1) | TWI309653B (zh) |
WO (1) | WO2006077035A1 (zh) |
ZA (1) | ZA200705674B (zh) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007065808A2 (en) * | 2005-12-07 | 2007-06-14 | F. Hoffmann-La Roche Ag | Neuropeptide-2 receptor-agonists |
US8299023B2 (en) * | 2008-09-17 | 2012-10-30 | Hoffmann-La Roche Inc. | Neuropeptide-2 receptor (Y-2R) agonists |
MX2011004427A (es) * | 2008-11-05 | 2011-05-31 | Hoffmann La Roche | Agonistas del receptor de neuropeptido-2 (y-2r) y usos de los mismos. |
WO2011002066A1 (ja) * | 2009-07-02 | 2011-01-06 | 武田薬品工業株式会社 | ペプチド及びその用途 |
JP2013505221A (ja) * | 2009-09-18 | 2013-02-14 | ノヴォ ノルディスク アー/エス | 長時間作用性y2受容体アゴニスト |
JP2013507414A (ja) * | 2009-10-13 | 2013-03-04 | エフ.ホフマン−ラ ロシュ アーゲー | 神経ペプチド−2受容体(y−2r)アゴニスト |
RS56998B1 (sr) | 2010-12-16 | 2018-05-31 | Novo Nordisk As | Čvrste kompozicije koje sadrže agonist glp-1 i so n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline |
WO2013139694A1 (en) | 2012-03-22 | 2013-09-26 | Novo Nordisk A/S | Compositions of glp-1 peptides and preparation thereof |
LT2861566T (lt) | 2012-06-13 | 2017-02-10 | F. Hoffmann-La Roche Ag | Nauji diazaspirocikloalkanai ir azaspirocikloalkanai |
CA2878442A1 (en) | 2012-09-25 | 2014-04-03 | F. Hoffmann-La Roche Ag | Hexahydropyrrolo[3,4-c]pyrrole derivatives and related compounds as autotaxin (atx) inhibitors and as inhibitors of the lysophosphatidic acid (lpa) production for treating e.g. renal diseases |
AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
US10583172B2 (en) | 2013-11-15 | 2020-03-10 | Novo Nordisk A/S | HPYY(1-36) having a beta-homoarginine substitution at position 35 |
CN105722526B (zh) | 2013-11-15 | 2020-12-08 | 诺和诺德股份有限公司 | 选择性pyy化合物及其用途 |
SI3074400T1 (en) | 2013-11-26 | 2018-03-30 | F. Hoffmann-La Roche Ag | Octahydro-cyclobut (1,2-c, 3,4-cy) dipyrrole derivatives as autoantaxine inhibitors |
UA118582C2 (uk) | 2014-03-26 | 2019-02-11 | Ф. Хоффманн-Ля Рош Аг | Біциклічні сполуки як інгібітори продукції аутотаксину (atx) і лізофосфатидилової кислоти (lpa) |
CN106029667B (zh) | 2014-03-26 | 2019-08-23 | 豪夫迈·罗氏有限公司 | 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的稠合[1,4]二氮杂*化合物 |
MA41898A (fr) * | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
KR102476550B1 (ko) | 2015-06-12 | 2022-12-13 | 노보 노르디스크 에이/에스 | 선택적인 pyy 화합물 및 그것의 사용 |
MX2020004504A (es) | 2015-09-04 | 2021-11-10 | Hoffmann La Roche | Derivados de fenoximetilo. |
JP6846414B2 (ja) | 2015-09-24 | 2021-03-24 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Atx阻害剤としての二環式化合物 |
BR112018006080A2 (pt) | 2015-09-24 | 2018-10-09 | F. Hoffmann-La Roche Ag | novos compostos bicíclicos como inibidores de dupla ação de atx/ca |
MX2017015034A (es) | 2015-09-24 | 2018-04-13 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca). |
CA2991615A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Bicyclic compounds as atx inhibitors |
WO2018167001A1 (en) | 2017-03-16 | 2018-09-20 | F. Hoffmann-La Roche Ag | Heterocyclic compounds useful as dual atx/ca inhibitors |
CN110382484B (zh) | 2017-03-16 | 2022-12-06 | 豪夫迈·罗氏有限公司 | 新的作为atx抑制剂的二环化合物 |
EP3717508A1 (en) | 2017-12-01 | 2020-10-07 | The University of Copenhagen | Peptide hormone with one or more o-glycans |
KR102647171B1 (ko) | 2018-02-02 | 2024-03-15 | 노보 노르디스크 에이/에스 | Glp-1 작용제 및 n-(8-(2-하이드록시벤조일)아미노)카프릴산의 염을 포함하는 고형 조성물 |
EP3800195A1 (en) * | 2019-10-03 | 2021-04-07 | Universitat de Barcelona | Peptide compounds for reducing side effects of cb1 receptor agonists |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5080891A (en) | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
HUT73494A (en) | 1993-03-29 | 1996-08-28 | Univ Cincinnati | Analogs of peptide yy and uses thereof |
US6017879A (en) * | 1998-04-03 | 2000-01-25 | B.M.R.A. Corporation B.V. | Template associated NPY Y2-receptor agonists |
EP1583549A4 (en) * | 2003-01-17 | 2006-10-04 | Sod Conseils Rech Applic | YY PEPTIDE ANALOGS |
JP2007512365A (ja) * | 2003-11-25 | 2007-05-17 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 選択的神経ペプチドy2受容体作動薬 |
AU2005211776B2 (en) * | 2004-02-11 | 2012-02-02 | Amylin Pharmaceuticals, Llc | Pancreatic polypeptide family motifs and polypeptides comprising the same |
-
2006
- 2006-01-10 US US11/328,743 patent/US7410949B2/en not_active Expired - Fee Related
- 2006-01-11 RU RU2007131504/04A patent/RU2383553C2/ru not_active IP Right Cessation
- 2006-01-11 DE DE602006020407T patent/DE602006020407D1/de active Active
- 2006-01-11 PL PL06700451T patent/PL1844070T3/pl unknown
- 2006-01-11 EP EP06700451A patent/EP1844070B1/en not_active Not-in-force
- 2006-01-11 ES ES06700451T patent/ES2359850T3/es active Active
- 2006-01-11 MX MX2007008614A patent/MX2007008614A/es active IP Right Grant
- 2006-01-11 WO PCT/EP2006/000161 patent/WO2006077035A1/en active Application Filing
- 2006-01-11 CN CNA2006800025981A patent/CN101107266A/zh active Pending
- 2006-01-11 AT AT06700451T patent/ATE500268T1/de active
- 2006-01-11 CA CA002594423A patent/CA2594423A1/en not_active Abandoned
- 2006-01-11 AU AU2006207659A patent/AU2006207659B2/en not_active Ceased
- 2006-01-11 JP JP2007551586A patent/JP4633804B2/ja not_active Expired - Fee Related
- 2006-01-11 BR BRPI0606675-5A patent/BRPI0606675A2/pt not_active Application Discontinuation
- 2006-01-11 KR KR1020077018848A patent/KR100905380B1/ko not_active IP Right Cessation
- 2006-01-11 DK DK06700451.5T patent/DK1844070T3/da active
- 2006-01-11 PT PT06700451T patent/PT1844070E/pt unknown
- 2006-01-16 AR ARP060100168A patent/AR051904A1/es active IP Right Grant
- 2006-01-16 TW TW095101606A patent/TWI309653B/zh not_active IP Right Cessation
-
2007
- 2007-07-05 IL IL184428A patent/IL184428A0/en unknown
- 2007-07-10 ZA ZA200705674A patent/ZA200705674B/xx unknown
- 2007-07-17 NO NO20073664A patent/NO20073664L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX2007008614A (es) | 2007-09-11 |
AU2006207659B2 (en) | 2009-10-29 |
ZA200705674B (en) | 2009-08-26 |
WO2006077035A9 (en) | 2006-10-26 |
KR20070095422A (ko) | 2007-09-28 |
ATE500268T1 (de) | 2011-03-15 |
JP2008527017A (ja) | 2008-07-24 |
PT1844070E (pt) | 2011-05-04 |
TW200637874A (en) | 2006-11-01 |
EP1844070A1 (en) | 2007-10-17 |
ES2359850T3 (es) | 2011-05-27 |
AU2006207659A1 (en) | 2006-07-27 |
CN101107266A (zh) | 2008-01-16 |
US7410949B2 (en) | 2008-08-12 |
DK1844070T3 (da) | 2011-06-14 |
BRPI0606675A2 (pt) | 2009-07-07 |
WO2006077035A1 (en) | 2006-07-27 |
EP1844070B1 (en) | 2011-03-02 |
JP4633804B2 (ja) | 2011-02-16 |
DE602006020407D1 (de) | 2011-04-14 |
IL184428A0 (en) | 2007-10-31 |
TWI309653B (en) | 2009-05-11 |
CA2594423A1 (en) | 2006-07-27 |
US20060160742A1 (en) | 2006-07-20 |
KR100905380B1 (ko) | 2009-06-30 |
PL1844070T3 (pl) | 2011-07-29 |
AR051904A1 (es) | 2007-02-14 |
RU2383553C2 (ru) | 2010-03-10 |
RU2007131504A (ru) | 2009-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20073664L (no) | Peptider med neuropeptid-2-reseptor (Y2R) agonist aktivitet | |
NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
NO2020031I1 (no) | kobimetinib, inklusive farmasøytisk akseptable salter og solvater, særlig kobimetinib hemifumarat | |
NO20083863L (no) | Pyrazoler som 11-beta-hsd-1 | |
NO20074872L (no) | Pyrazoler | |
EA201070167A1 (ru) | Замещенные производные индазола, активные как ингибиторы киназы | |
EA200970595A1 (ru) | Производные замещенных индазолов, активные в качестве ингибиторов киназ | |
EA200970585A1 (ru) | Бензамидные производные как агонисты ер-рецепторов | |
NO20063620L (no) | Arylanilinderivater som beta2 adrenergiske receptoragonister | |
NO20090628L (no) | Pyridizinon derivativater | |
NO20081844L (no) | Terapeutiske forbindelser | |
NO20060001L (no) | Nye P2X7-reseptorantagonister og deres anvendelse | |
DK1636236T3 (da) | Pyrazolo-quinazolin-derivater, en fremgangsmåde til fremstilling deraf, og deres anvendelse som kinase-inhibitorer | |
NO20092737L (no) | Substituerte pyrazolo-kinazolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som kinase-inhibitorer | |
DK2324008T3 (da) | Diarylpyrazol som protein kinase inhibitorer | |
GEP20094727B (en) | Oxyindole derivatives as 5ht4 receptor agonists | |
NO20080484L (no) | Niacin-reseptorantagonister, preparater inneholdende slike forbindelser og behandlingsmetoder | |
NO20056132L (no) | Krystallinsk form av beta2 adrenergisk receptoragonist | |
ATE442349T1 (de) | Diacylglycerol-acyltransferase-hemmer | |
NO20080164L (no) | N-(pyridin-2-yl)-sulfonamidderivater | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20076418L (no) | Heterocyclic compounds as agonists for the thyroid receptor | |
ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
DE602006018713D1 (de) | Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate | |
NO20085099L (no) | Puritonderivativer som HM74A agonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |